Lung Cancer

Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial

Figure 1 from Lung Cancer
Open the figure at full size
Figure 1. Ledda et al.
Trial in 4,119 peopleInterventions

9.4 years, cohort study, declared no competing interests

The paper